Cargando…
Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
BACKGROUND AND PURPOSE—: A variant in the histone deacetylase 9 (HDAC9) gene is associated with large artery stroke. Therefore, inhibiting HDAC9 might offer a novel secondary preventative treatment for ischemic stroke. The antiepileptic drug sodium valproate (SVA) is a nonspecific inhibitor of HDAC9...
Autores principales: | Brookes, Rebecca L., Crichton, Siobhan, Wolfe, Charles D.A., Yi, Qilong, Li, Linxin, Hankey, Graeme J., Rothwell, Peter M., Markus, Hugh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753817/ https://www.ncbi.nlm.nih.gov/pubmed/29247141 http://dx.doi.org/10.1161/STROKEAHA.117.016674 |
Ejemplares similares
-
Etiological Subtypes of Transient Ischemic Attack and Ischemic Stroke in Chronic Kidney Disease: Population-Based Study
por: Kelly, Dearbhla M., et al.
Publicado: (2020) -
Prognostic Significance of Blood Pressure Variability on Beat-to-Beat Monitoring After Transient Ischemic Attack and Stroke
por: Webb, Alastair J.S., et al.
Publicado: (2018) -
External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients
por: Hilkens, Nina A., et al.
Publicado: (2018) -
Clinical Correlates, Ethnic Differences, and Prognostic Implications of Perivascular Spaces in Transient Ischemic Attack and Ischemic Stroke
por: Lau, Kui-Kai, et al.
Publicado: (2017) -
Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease
por: Boulanger, Marion, et al.
Publicado: (2019)